(MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.21
-0.02 (-1.63%)
At close: Apr 30, 2025, 3:59 PM
1.19
-1.24%
After-hours: Apr 30, 2025, 04:00 PM EDT
-1.63% (1D)
Bid | 1.16 |
Market Cap | 13.63M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.19 |
PE Ratio (ttm) | -1.01 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 1.49 |
Volume | 36,796 |
Avg. Volume (20D) | 124,814 |
Open | 1.20 |
Previous Close | 1.23 |
Day's Range | 1.19 - 1.22 |
52-Week Range | 0.95 - 5.99 |
Beta | undefined |
Analyst Forecast
According to 3 analyst ratings, the average rating for MRKR stock is "Strong Buy." The 12-month stock price forecast is $12.5, which is an increase of 937.34% from the latest price.
Stock ForecastsNext Earnings Release
is scheduled to release its earnings on May 14, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
Marker Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
4 months ago
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.